RAS testing practices and RAS mutation prevalence among patients with metastatic colorectal cancer: results from a Europe-wide survey of pathology centres
about
RAS mutation prevalence among patients with metastatic colorectal cancer: a meta-analysis of real-world data.Detection of KRAS G12D in colorectal cancer stool by droplet digital PCR.Association between clinicopathological characteristics and RAS mutation in colorectal cancer.RAS testing for colorectal cancer patients is reliable in European laboratories that pass external quality assessment.
P2860
RAS testing practices and RAS mutation prevalence among patients with metastatic colorectal cancer: results from a Europe-wide survey of pathology centres
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
RAS testing practices and RAS ...... de survey of pathology centres
@ast
RAS testing practices and RAS ...... de survey of pathology centres
@en
type
label
RAS testing practices and RAS ...... de survey of pathology centres
@ast
RAS testing practices and RAS ...... de survey of pathology centres
@en
prefLabel
RAS testing practices and RAS ...... de survey of pathology centres
@ast
RAS testing practices and RAS ...... de survey of pathology centres
@en
P2093
P2860
P1433
P1476
RAS testing practices and RAS ...... de survey of pathology centres
@en
P2093
Aliki Taylor
Els Dequeker
George Kafatos
Lien Tembuyser
Sophie Jenkins-Anderson
Véronique Tack
P2860
P2888
P356
10.1186/S12885-016-2810-3
P407
P577
2016-10-26T00:00:00Z
P6179
1049421114